- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07735884
Comparison of Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Tramadol for Positioning of Femur Fracture Patients Before Spinal Anaesthesia
This randomized clinical study compared two methods of pain relief used before spinal anaesthesia in patients undergoing surgery for a femur fracture. Positioning a patient with a fractured femur into the side-lying position required for spinal anaesthesia can cause severe pain because movement may disturb the fractured bone.
A total of 64 patients aged 18 to 60 years were included and were assigned to one of two treatment groups. One group received intravenous tramadol, while the other group received an ultrasound-guided fascia iliaca compartment block, in which local anaesthetic was injected near the nerves supplying the hip and upper thigh. Pain was measured using a visual analogue scale when the patient arrived on the operating table and again during positioning in the lateral decubitus position before spinal anaesthesia.
The study was conducted to determine which treatment provided better pain relief and made positioning for spinal anaesthesia more comfortable. It was hypothesized that the ultrasound-guided fascia iliaca compartment block would reduce pain during positioning more effectively than intravenous tramadol.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Mayo Hospital, Lahore
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Age 18-60 years
- Male or female patients
- American Society of Anesthesiologists physical status I or II
- Patients scheduled for femur fracture surgery under spinal anaesthesia
Exclusion Criteria:
- Multiple fractures
- Peripheral neuropathy
- Inability to communicate or provide reliable pain assessment
- History of allergy to local anaesthetic agents
Contraindication to spinal anaesthesia, including:
- Patient refusal
- Local infection at the injection site
- Coagulopathy
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Ultrasound-Guided Fascia Iliaca Compartment Block Group
Participants received an ultrasound-guided fascia iliaca compartment block through the infrainguinal approach using 30 mL of 1% lidocaine with adrenaline.
After 15 minutes, participants were positioned in the lateral decubitus position for spinal anaesthesia, and pain intensity was assessed using the visual analogue scale.
|
An ultrasound-guided infrainguinal fascia iliaca compartment block was administered with 30 mL of 1% lidocaine containing adrenaline.
|
|
Aktiver Komparator: Intravenous Tramadol Group
Participants received intravenous tramadol at a dose of 1 mg/kg.
After 10 minutes, participants were positioned in the lateral decubitus position for spinal anaesthesia, and pain intensity was assessed using the visual analogue scale.
|
Tramadol was administered intravenously at a dose of 1 mg/kg before positioning for spinal anaesthesia.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Pain Intensity During Positioning for Spinal Anaesthesia
Zeitfenster: 10 minutes after intravenous tramadol or 15 minutes after ultrasound-guided fascia iliaca compartment block, immediately before spinal anaesthesia.
|
Pain intensity was assessed using a 0-10 visual analogue scale during placement of the participant in the lateral decubitus position before spinal anaesthesia.
A score of 0 represented no pain, while a score of 10 represented the worst possible pain.
Lower scores indicated better analgesic efficacy.
|
10 minutes after intravenous tramadol or 15 minutes after ultrasound-guided fascia iliaca compartment block, immediately before spinal anaesthesia.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Visual Analogue Scale Pain Score From Baseline to Positioning
Zeitfenster: 10 minutes after intravenous tramadol or 15 minutes after fascia iliaca compartment block.
|
The change in pain intensity was determined by comparing the visual analogue scale score recorded while the participant was lying on the operating table before the assigned intervention with the score recorded during lateral decubitus positioning.
A greater reduction in score indicated greater analgesic effectiveness.
|
10 minutes after intravenous tramadol or 15 minutes after fascia iliaca compartment block.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Adeel Ahmed, Mayo Hospital Lahore
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Schmerzen
- Neurologische Manifestationen
- Wunden und Verletzungen
- Beinverletzungen
- Frakturen, Knochen
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Femurfrakturen
- Akuter Schmerz
- Organische Chemikalien
- Lipide
- Amine
- Alkohole
- Cyclohexanole
- Hexanole
- Fettalkohole
- Dimethylamine
- Methylamine
- Tramadol
Andere Studien-ID-Nummern
- Mayo8
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .